RARB and neoplasm: Similarly, Ostrow et al. validated in plasma a group of four genes (DCC, Kif1a, NISCH, RARB) that was previously found in tumors, which discriminated between LuCa patients and tumor-free individuals, with a sensitivity of 73% and specificity of 71% [61].